Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Wermke

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Transplantation|May 31, 2012
Reconstitution of 6-sulfo LacNAc dendritic cells after allogeneic stem-cell transplantationKonrad Mager, Rebekka Wehner, Felix Bahr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2025
Phase I Dose-Escalation Results for the Delta-Like Ligand 3/CD3 IgG-Like T-Cell Engager Obrixtamig (BI 764532) in Patients With Delta-Like Ligand 3+ Small Cell Lung Cancer or Neuroendocrine CarcinomasMartin Wermke, Valentina Gambardella, Yasutoshi Kuboki, et al.
International Journal of Molecular Sciences|January 21, 2022
Comparison of FACS and PCR for Detection of BCMA-CAR-T CellsAvinoam Reichman, Alexander Kunz, Jara J Joedicke, et al.
British Journal of Cancer|April 7, 2021
Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpressionThomas Decaens, Carlo Barone, Eric Assenat, et al.
Oncoimmunology|November 11, 2017
Characterization of a switchable chimeric antigen receptor platform in a pre-clinical solid tumor modelElham Pishali Bejestani, Marc Cartellieri, Ralf Bergmann, et al.
Cytotherapy|December 30, 2019
Reliable isolation of human mesenchymal stromal cells from bone marrow biopsy specimens in patients after allogeneic hematopoietic cell transplantationThomas Krüger, Jan Moritz Middeke, Friedrich Stölzel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2020
Phase 1 Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naive NSCLCRoy S Herbst, Hendrik Tobias Arkenau, Johanna Bendell, et al.
Lung Cancer (Amsterdam, Netherlands)|January 8, 2022
Pathologic responses in oligometastatic NSCLC patients treated with neoadjuvant immune checkpoint blockade with and without chemotherapy followed by surgeryTobias Boch, Nikolaj Frost, Linna Sommer, et al.
Blood|May 6, 2010
A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trialChristoph Röllig, Christian Thiede, Martin Gramatzki, et al.
Blood|May 5, 2011
Prophylactic transfer of BCR-ABL-, PR1-, and WT1-reactive donor T cells after T cell-depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemiaMartin Bornhäuser, Christian Thiede, Uwe Platzbecker, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Transplantation|May 31, 2012
Reconstitution of 6-sulfo LacNAc dendritic cells after allogeneic stem-cell transplantationKonrad Mager, Rebekka Wehner, Felix Bahr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2025
Phase I Dose-Escalation Results for the Delta-Like Ligand 3/CD3 IgG-Like T-Cell Engager Obrixtamig (BI 764532) in Patients With Delta-Like Ligand 3+ Small Cell Lung Cancer or Neuroendocrine CarcinomasMartin Wermke, Valentina Gambardella, Yasutoshi Kuboki, et al.
International Journal of Molecular Sciences|January 21, 2022
Comparison of FACS and PCR for Detection of BCMA-CAR-T CellsAvinoam Reichman, Alexander Kunz, Jara J Joedicke, et al.
British Journal of Cancer|April 7, 2021
Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpressionThomas Decaens, Carlo Barone, Eric Assenat, et al.
Oncoimmunology|November 11, 2017
Characterization of a switchable chimeric antigen receptor platform in a pre-clinical solid tumor modelElham Pishali Bejestani, Marc Cartellieri, Ralf Bergmann, et al.
Cytotherapy|December 30, 2019
Reliable isolation of human mesenchymal stromal cells from bone marrow biopsy specimens in patients after allogeneic hematopoietic cell transplantationThomas Krüger, Jan Moritz Middeke, Friedrich Stölzel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2020
Phase 1 Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naive NSCLCRoy S Herbst, Hendrik Tobias Arkenau, Johanna Bendell, et al.
Lung Cancer (Amsterdam, Netherlands)|January 8, 2022
Pathologic responses in oligometastatic NSCLC patients treated with neoadjuvant immune checkpoint blockade with and without chemotherapy followed by surgeryTobias Boch, Nikolaj Frost, Linna Sommer, et al.
Blood|May 6, 2010
A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trialChristoph Röllig, Christian Thiede, Martin Gramatzki, et al.
Blood|May 5, 2011
Prophylactic transfer of BCR-ABL-, PR1-, and WT1-reactive donor T cells after T cell-depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemiaMartin Bornhäuser, Christian Thiede, Uwe Platzbecker, et al.
Pageof 9